ENTA (ENTA) Stock Price & Analysis
ENTA (ENTA) rose 0.43% to USD 14.08 as of September 8, 2026 at 05:00 UTC, according to Nexqual real-time market data.
ENTA last closed at USD 14.08; the session ranged USD 13.45–14.23 on volume of 233,450 shares. Market capitalization is —, with a 52-week range of USD 7.05–17.15 (NMS). Source: Nexqual, September 8, 2026 at 05:00 UTC.
Key Statistics (as of September 8, 2026 at 05:00 UTC)
| Price | USD 14.08 |
|---|---|
| Change | ▲ 0.43% (up) |
| Previous Close | USD 14.08 |
| Open | USD 14.08 |
| Day Range | USD 13.45 – 14.23 |
| 52-Week Range | USD 7.05 – 17.15 |
| Volume | 233,450 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ENTA)
Nexqual's technical model rates ENTA "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 05:00 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.93 (neutral) |
| vs SMA50 | Above (USD 13.58) |
| MACD | 0.17 (positive) |
From ENTA's Latest SEC 10-K Filing (filed 2025-11-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XNCR | Xencor, Inc. | USD 26.61 | ▼ 1.08% |
| PTCT | PTC Therapeutics, Inc. | USD 69.3 | ▼ 3.47% |
| AGIO | Agios Pharmaceuticals, Inc. | USD 33.1 | ▼ 3.02% |
| MGNX | MacroGenics, Inc. | USD 4.4 | ▲ 1.85% |
| ANAB | AnaptysBio, Inc. | USD 56.8 | ▲ 1.72% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:00 UTC. This page is informational and not investment advice.